Want to join the conversation?
$ESRX, which competes with $UNH and $ANTM, said that the the company delivers on controlling costs and achieving better patient outcomes. In situations where drug prices rise and complex regulations increase, the company finds out innovative ways to strengthen the pharmacy benefit, while improving care.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.